Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,744.00
Bid: 4,744.00
Ask: 4,748.00
Change: -146.00 (-2.99%)
Spread: 4.00 (0.084%)
Open: 4,884.00
High: 4,884.00
Low: 4,716.00
Prev. Close: 4,890.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intertek Acquires Pharmaceutical Testing Company Alta Analytical Laboratory

5 Dec 2006 07:00

Intertek Group Plc (Intertek), the leading international providerof quality and safety services to a wide range of industries,announces that its Oil, Chemical and Agri division (Caleb Brett) hasacquired Alta Analytical Laboratories Inc. (Alta). £ Alta is a leading supplier of Immunochemistry and LC/MS/MSbio-analytical services to the pharmaceutical and biotech industriesin North America. Alta has laboratories located in San Diego and nearSacramento, California with approximately 110 staff and counts majorglobal pharmaceutical companies among its clients. Both laboratoriesare known for their technical expertise, rigorous compliance programs,and excellent customer service. £ The acquisition will advance Intertek's strategic growth insupporting the global pharmaceutical and biotech industries throughthe provision of extensive method development capabilities and acomprehensive range of state of the art analytical testing services.Intertek's Executive Vice President and CEO of the Caleb BrettDivision, Mark Loughead, comments: "Alta has earned an outstandingreputation for quality and service and its expertise will furtherexpand our ability to respond to the needs of the pharmaceutical andbiopharmaceutical industry for outsourced R&D and testing support. Itestablishes a firm platform for further development for Intertek inthe USA." Intertek already provides testing services to pharmaceuticalclients from its laboratories in the UK. £ Bob Bethem and Jo Smolec, Ph.D., the Alta Analytical Laboratorybusiness heads, comment: "Acquisition by Intertek allows Alta theability to invest in the next phase of expansion to grow our servicesand offer extended expertise to our existing clients. Becoming part ofIntertek's global business and reach provides a powerful opportunityto expand our bio-analytical services to existing and newinternational customers and markets." £ About Intertek: £ Intertek Group Plc (FTSE:ITRK) is a leading international providerof quality and safety services to a wide range of global and localindustries. Partnership with Intertek brings increased value tocustomers' products and processes, ultimately supporting their successin the global market place. Intertek has the experience, expertise,resources and global reach to support its customers through theirnetwork of 910 laboratories and offices, 17,400 people in 110countries around the world. www.intertek.com £ About Intertek's pharmaceutical services: £ Intertek's Oil, Chemical & Agri division, Intertek Caleb Brett,provides 24/7/365 testing and inspection services to the globalchemical, petroleum and refining industries and provides a wide rangeof routine and non-routine laboratory testing services to supportpharmaceutical, biotechnology and nanotechnology clients. A growinginternational network of Intertek laboratories serves clients on aglobal basis with services including laboratory testing, outsourcing,inspection, R&D and process services. Intertek laboratories areideally suited to support a diverse range of fine chemical,pharmaceutical and biotech activities.www.intertek-cb.com/newsitetest/services/pharmaceutical/index.shtml £ About Alta Analytical Laboratory: £ Alta Analytical Laboratory is a contract testing laboratory withlocations in two California, USA sites: Sacramento and San Diego. Altaprovides liquid chromatography mass spectrometry (LC-MS/MS) andimmunochemistry contract laboratory services to pharmaceutical,biotech and chemical clients. Since 1990, Alta has provided GoodLaboratory Practice (GLP) services for early drug development, andpre-clinical and clinical studies out of its LC-MS/MS lab nearSacramento. The company added immunochemistry services in San Diego in1999. Alta's primary strength lies in its ability to rapidly developrobust and sensitive analytical methodologies and efficiently utilizethese novel methods in a high throughput setting.http://www.altalab.com/ £ High resolution images of Intertek Group Plc businesses areavailable to download, free of charge from www.vismedia.co.uk Copyright Business Wire 2006
Date   Source Headline
6th Jun 20241:00 pmRNSDirector/PDMR Shareholding
29th May 20241:00 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSDirectorate Change
24th May 20241:30 pmRNSResult of AGM
24th May 20247:00 amRNSTrading Statement
22nd May 20241:00 pmRNSBlock listing Interim Review
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.